
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sixty Degree Capital is a global investment firm founded in 2017 and headquartered in Toronto, Canada. The firm specializes in investing in high-potential companies within the healthcare and technology sectors. Currently, Sixty Degree Capital manages over $620 million in assets under management (AUM) and has successfully completed more than 12 exits, including notable acquisitions such as CinCor Pharma by AstraZeneca in 2023.
The firm operates with a team of over 20 professionals and has expanded its presence with offices in San Francisco, Silicon Valley, and New York. Sixty Degree Capital has established itself as a significant player in the venture capital space, particularly for Canadian firms, by focusing on transformative investments that align with market needs.
Since its inception, Sixty Degree Capital has evolved its investment strategy to encompass a wide range of stages, from pre-seed to growth equity, allowing it to support companies at various points in their development. The firm’s notable milestones include the successful launch of Fund III, which raised $250 million USD, underscoring its ability to attract capital and invest in promising startups.
Sixty Degree Capital employs a thesis-driven investment strategy that emphasizes rigorous analysis and operational support. The firm invests across multiple stages, including pre-seed, seed, Series A, Series A Plus, Series B, growth equity, and pre-IPO. The check size ranges from $1 million to $10 million, allowing flexibility in funding various types of startups.
The sectors of focus include technology, specifically artificial intelligence (AI), cybersecurity, digital infrastructure, and software as a service (SaaS), as well as healthcare, which encompasses drug development, diagnostics, digital health, and medical devices. This dual focus enables Sixty Degree Capital to identify and invest in high-potential companies that are positioned to drive significant change in their respective industries.
In addition to financial investment, Sixty Degree Capital provides operational support and strategic guidance to its portfolio companies. This approach helps startups navigate competitive markets and accelerates their growth trajectories, making the firm an attractive partner for emerging businesses.
Sixty Degree Capital's portfolio includes a diverse range of companies that exemplify its investment strategy across healthcare and technology sectors. Notable portfolio companies include:
This portfolio reflects Sixty Degree Capital's commitment to investing in innovative companies that are poised for growth and success in their respective markets.
Robert Guo, MBA - CEO. Robert has extensive experience in venture capital and has led multiple successful investments in the technology and healthcare sectors.
Cheryl Kuai, PhD, CFA - Managing Director. Cheryl brings a strong background in biotech and healthcare investments, having previously worked at leading investment firms.
Vincent Ho, CPA - Director, Fund Operations. Vincent oversees fund operations and has a solid track record in financial management within the venture capital space.
Robin Gao, MMI - Principal. Robin focuses on technology investments and has experience in scaling startups in the AI and cybersecurity sectors.
Lillian Yu - Analyst, Fund Operations. Lillian supports fund operations and analysis, contributing to the firm's investment decision-making process.
Nate Xia, PhD, CFA - Principal. Nate specializes in healthcare investments and has a strong background in clinical research and drug development.
Brett Liu, MEng, CFA - Principal. Brett focuses on technology investments, particularly in SaaS and digital infrastructure.
Sintia Teichman, PhD - Principal. Sintia has expertise in biotech investments and has worked on several successful exits in the sector.
Kenneth Grisé, PhD - Principal. Kenneth specializes in healthcare and medical device investments, bringing a wealth of knowledge to the team.
Hoyin Yip, PhD - Associate. Hoyin supports the investment team with research and analysis in technology sectors.
Jenny Lo, MBA - Principal. Jenny focuses on strategic investments in healthcare and has a strong background in operational support.
Jojo Ye, MBA - Associate. Jojo assists in deal sourcing and portfolio management, contributing to the firm's growth strategy.
Mohan Zhang - Principal. Mohan has extensive experience in venture capital and focuses on technology investments.
Sarah Blicker - Associate. Sarah supports the investment team with market research and analysis.
To pitch Sixty Degree Capital, founders should submit their proposals through the firm's website at sixtydegreecapital.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and financial projections.
Sixty Degree Capital prefers well-structured decks that clearly articulate the startup's vision and growth strategy. Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In 2023, Sixty Degree Capital achieved a significant milestone with the acquisition of its portfolio company, CinCor Pharma, by AstraZeneca for $1.8 billion. This exit highlights the firm's ability to identify and support high-potential biotech companies.
Sixty Degree Capital's Fund III, which raised $250 million USD, is actively deploying capital into promising startups, including investments in Cato Networks, Docker, and NextPoint. The firm continues to expand its portfolio with a focus on transformative healthcare and technology investments.
Recent updates on their website emphasize the firm's commitment to operational support and strategic guidance for portfolio companies, reinforcing its reputation as a leading venture capital firm in Canada.
What are Sixty Degree Capital's investment criteria?
Sixty Degree Capital invests in high-potential companies across various stages, from pre-seed to growth equity. The firm focuses on sectors such as AI, cybersecurity, digital infrastructure, SaaS, and healthcare, including drug development and diagnostics.
How can I apply or pitch to Sixty Degree Capital?
Founders can pitch their ideas through the firm's website at sixtydegreecapital.com. It is recommended to include a detailed business plan, market analysis, and financial projections in the pitch deck.
What makes Sixty Degree Capital different from other investors?
Sixty Degree Capital distinguishes itself through its operational support and strategic guidance, which helps portfolio companies scale effectively. The firm emphasizes a thesis-driven approach to investment, ensuring rigorous analysis before committing capital.
What is the geographic scope of Sixty Degree Capital's investments?
The firm invests globally, with a strong focus on North America, particularly the United States and Canada. This geographic focus allows them to tap into leading markets for technology and healthcare innovation.
What is the typical fund size and check size for investments?
Sixty Degree Capital manages over $620 million in assets across its funds, with Fund III specifically raising $250 million. The check sizes for investments typically range from $1 million to $10 million.
What is Sixty Degree Capital's post-investment involvement like?
The firm provides ongoing operational support and strategic guidance to its portfolio companies, helping them navigate challenges and capitalize on growth opportunities. This involvement often includes board representation and access to the firm's extensive network.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.